Proteomic analysis reveals that the protective effects of ginsenoside rb1 are associated with the actin cytoskeleton in β-amyloid-treated neuronal cells

Journal of Ginseng Research

Volumn 40, Issue 3, 2016, Pages 278-284

  Hwang, Ji Yeon ^a   Shim, Ji Seon ^a   Song, Min Young ^a   Yim, Sung Vin ^a   Lee, Seung Eun ^b   Park, Kang Sik ^a  

^a Kyung Hee University Hospital   (South Korea)

^b Rural Development Administration   (South Korea)

Author keywords

Actin skeleton; Alzheimer s disease; Ginsenoside Rb1; Mass spectrometry; amyloid

Indexed keywords

26S PROTEASE REGULATORY SUBUNIT 6A; 60S RIBOSOMAL PROTEIN L29; ADENYLYL CYCLASE ASSOCIATED PROTEIN 1; ALANINE TRANSFER RNA LIGASE; ATP BINDING CASSETTE SUBFAMILY E MEMBER 1; CALCIUM REGULATED HEAT STABLE PROTEIN 1; CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR SUBUNIT 5; COFILIN 1; GINSENOSIDE RB 1; HEAT SHOCK 70 KDA PROTEIN 6; HISTONE H1 2; HISTONE H1 3; HISTONE H1 4; IQ MOTIF CONTAINING GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN 1; ISOFORM 2 OF ATPASE FAMILY AAA DOMAIN CONTAINING PROTEIN 1; ISOFORM 2 OF BIFUNCTIONAL PURINE BIOSYNTHESIS PROTEIN PURH; ISOFORM 2 OF DESTRIN; ISOFORM 2 OF F ACTIN CAPPING PROTEIN SUBUNIT BETA; ISOFORM 2 OF G RICH SEQUENCE FACTOR 1; ISOFORM 2 OF GALACTOKINASE; ISOFORM 2 OF LON PROTEASE HOMOLOG; ISOFORM 2 OF SERINE ARGININE RICH SPLICING FACTOR 3; ISOFORM 2 OF STOMATIN LIKE PROTEIN 2; ISOFORM 2 OF TROPOMYOSIN BETA CHAIN; ISOFORM 2 OF XAA PRO DIPEPTIDASE; ISOFORM 2 OF [3 METHYL 2 OXOBUTANOATE DEHYDROGENASE[LIPOAMIDE]KINASE; MITOCHONDRIAL IMPORT RECEPTOR SUBUNIT TOM40 HOMOLOG; NADH DEHYDROGENASE[UBIQUINONE]1 ALPHA SUBCOMPLEX SUBUNIT 9; PEPTIDES AND PROTEINS; SACCHAROPINE DEHYDROGENASE LIKE OXIDOREDUCTASE; UNCLASSIFIED DRUG;

ACTIN FILAMENT; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ISOTOPE LABELING; NEUROPROTECTION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; PROTEOMICS;

EID: 84951753701     PISSN: 12268453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jgr.2015.09.004     Document Type: Article

References (40)

1. Radad K, Gille G, Liu L, Rausch WD. Use of ginseng in medicine with emphasis on neurodegenerative disorders. J Pharmacol Sci 2006;100:175-86.
2. Lee ST, Chu K, Sim JY, Heo JH, Kim M. Panax ginseng enhances cognitive performance in Alzheimer disease. Alzheimer Dis Assoc Disord 2008;22:222-6.
3. Van Kampen JM, Baranowski DB, Shaw CA, Kay DG. Panax ginseng is neuroprotective in a novel progressive model of Parkinson’s disease. Exp Gerontol 2014;50:95-105.
4. Liu CX, Xiao PG. Recent advances on ginseng research in China. J Ethnopharmacol 1992;36:27-38.
5. Liao B, Newmark H, Zhou R. Neuroprotective effects of ginseng total saponin and ginsenosides Rb1 and Rg1 on spinal cord neurons in vitro. Exp Neurol 2002;173:224-34.
6. Yoshikawa T, Akiyoshi Y, Susumu T, Tokado H, Fukuzaki K, Nagata R, Samukawa K, Iwao H, Kito G. Ginsenoside Rb1 reduces neurodegeneration in the peri-infarct area of a thromboembolic stroke model in non-human primates. J Pharmacol Sci 2008;107:32-40.
7. Lim JH, Wen TC, Matsuda S, Tanaka J, Maeda N, Peng H, Aburaya J, Ishihara K, Sakanaka M. Protection of ischemic hippocampal neurons by ginsenoside Rb1, a main ingredient of ginseng root. Neurosci Res 1997;28:191-200.
8. Wang Y, Feng Y, Fu Q, Li L. Panax notoginsenoside Rb1 ameliorates Alzheimer’s disease by upregulating brain-derived neurotrophic factor and downregulating Tau protein expression. Exp Ther Med 2013;6:826-30.
9. Xie X, Wang HT, Li CL, Gao XH, Ding JL, Zhao HH, Lu YL. Ginsenoside Rb1 protects PC12 cells against beta-amyloid-induced cell injury. Mol Med Rep 2010;3:635-9.
10. Qian YH, Han H, Hu XD, Shi LL. Protective effect of ginsenoside Rb1 on betaamyloid protein(1-42)-induced neurotoxicity in cortical neurons. Neurol Res 2009;31:663-7.
11. Wang Y, Liu J, Zhang Z, Bi P, Qi Z, Zhang C. Anti-neuroinflammation effect of ginsenoside Rbl in a rat model of Alzheimer disease. Neurosci Lett 2011;487: 70-2.
12. Han G, Sun J, Wang J, Bai Z, Song F, Lei H. Genomics in neurological disorders. Genomics Proteomics Bioinformatics 2014;12:156-63.
13. Sowell RA, Owen JB, Butterfield DA. Proteomics in animal models of Alzheimer’s and Parkinson’s diseases. Ageing Res Rev 2009;8:1-17.
14. Sultana R, Butterfield DA. Redox proteomics studies of in vivo amyloid betapeptide animal models of Alzheimer’s disease: insight into the role of oxidative stress. Proteomics Clin Appl 2008;2:685-96.
15. Swomley AM, Forster S, Keeney JT, Triplett J, Zhang Z, Sultana R, Butterfield DA. Abeta, oxidative stress in Alzheimer disease: evidence based on proteomics studies. Biochim Biophys Acta 2014;1842:1248-57.
16. Lee SY, Kim GT, Roh SH, Song JS, Kim HJ, Hong SS, Kwon SW, Park JH. Proteomic analysis of the anti-cancer effect of 20S-ginsenoside Rg3 in human colon cancer cell lines. Biosci Biotechnol Biochem 2009;73:811-6.
17. Cho WC, Yip TT, Chung WS, Lee SK, Leung AW, Cheng CH, Yue KKM. Altered expression of serum protein in ginsenoside Re-treated diabetic rats detected by SELDI-TOF MS. J Ethnopharmacol 2006;108:272-9.
18. Ma ZC, Gao Y, Wang YG, Tan HL, Xiao CR, Wang SQ. Ginsenoside Rg1 inhibits proliferation of vascular smooth muscle cells stimulated by tumor necrosis factor-alpha. Acta Pharmacol Sin 2006;27:1000-6.
19. Choi JW, Song MY, Park KS. Quantitative proteomic analysis reveals mitochondrial protein changes in MPP(þ)-induced neuronal cells. Mol Biosyst 2014;10:1940-7.
20. Szklarczyk D, Franceschini A, Kuhn M, Simonovic M, Roth A, Minguez P, Doerks T, Stark M, Muller J, Bork P, et al. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res 2011;39:D561-8.
21. Abeti R, Abramov AY, Duchen MR. Beta-amyloid activates PARP causing astrocytic metabolic failure and neuronal death. Brain 2011;134:1658-72.
22. Huang DW, Sherman BT, Tan Q, Kir J, Liu D, Bryant D, Guo Y, Stephens R, Baseler RW, Lane HC, et al. DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists. Nucleic Acids Res 2007;35:W169-75.
23. McMurray CT. Neurodegeneration: diseases of the cytoskeleton? Cell Death Differ 2000;7:861-5.
24. Li H, Zhu YH, Chi C, Wu HW, Guo J. Role of cytoskeleton in axonal regeneration after neurodegenerative diseases and CNS injury. Rev Neurosci 2014;25:527-42.
25. Penzes P, Vanleeuwen JE. Impaired regulation of synaptic actin cytoskeleton in Alzheimer’s disease. Brain Res Rev 2011;67:184-92.
26. Kao PF, Davis DA, Banigan MG, Vanderburg CR, Seshadri S, Delalle I. Modulators of cytoskeletal reorganization in CA1 hippocampal neurons show increased expression in patients at mid-stage Alzheimer’s disease. PLoS One 2010;5:e13337.
27. Zhang H, Ghai P, Wu H, Wang C, Field J, Zhou GL. Mammalian adenylyl cyclase-associated protein 1 (CAP1) regulates cofilin function, the actin cytoskeleton, and cell adhesion. J Biol Chem 2013;288:20966-77.
28. Yamazaki K, Takamura M, Masugi Y, Mori T, Du W, Hibi T, Hiraoka N, Ohta T, Ohki M, Hirohashi S. Adenylate cyclase-associated protein 1 overexpressed in pancreatic cancers is involved in cancer cell motility. Lab Invest 2009;89: 425-32.
29. He J, Whelan SA, Lu M, Shen D, Chung DU, Saxton RE, Faull KF, Whitelegge JP, Chang HR. Proteomic-based biosignatures in breast cancer classification and prediction of therapeutic response. Int J Proteomics 2011;2011:896476.
30. Moriyama K, Yahara I. Human CAP1 is a key factor in the recycling of cofilin and actin for rapid actin turnover. J Cell Sci 2002;115:1591-601.
31. Zhu X, Yao L, Guo A, Li A, Sun H, Wang N, Liu H, Duan Z, Cao J. CAP1 was associated with actin and involved in Schwann cell differentiation and motility after sciatic nerve injury. J Mol Histol 2014;45:337-48.
32. Mitake S, Ojika K, Hirano A. Hirano bodies and Alzheimer’s disease. Kaohsiung J Med Sci 1997;13:10-8.
33. Delalle I, Pfleger CM, Buff E, Lueras P, Hariharan IK. Mutations in the Drosophila orthologs of the F-actin capping protein alpha-and beta-subunits cause actin accumulation and subsequent retinal degeneration. Genetics 2005;171:1757-65.
34. Davis DA, Wilson MH, Giraud J, Xie Z, Tseng HC, England C, Herscovitz H, Tsai LH, Delalle I. Capzb2 interacts with beta-tubulin to regulate growth cone morphology and neurite outgrowth. PLoS Biol 2009;7:e1000208.
35. Tian L, Liao MF, Zhang L, Lu QS, Jing ZP. A study of the expression and interaction of Destrin, cofilin, and LIMK in Debakey I type thoracic aortic dissection tissue. Scand J Clin Lab Invest 2010;70:523-8.
36. Klose T, Abiatari I, Samkharadze T, De Oliveira T, Jager C, Kiladze M, Valkovska N, Friess H, Michalski CW, Kleeff J. The actin binding protein destrin is associated with growth and perineural invasion of pancreatic cancer. Pancreatology 2012;12:350-7.
37. Barone E, Mosser S, Fraering PC. Inactivation of brain Cofilin-1 by age, Alzheimer’s disease and gamma-secretase. Biochim Biophys Acta 2014;1842: 2500-9.
38. Elias-Sonnenschein LS, Helisalmi S, Natunen T, Hall A, Paajanen T, Herukka SK, Laitinen M, Remes AM, Koivisto AM, Mattila KM, et al. Genetic loci associated with Alzheimer’s disease and cerebrospinal fluid biomarkers in a Finnish casecontrol cohort. PLoS One 2013;8:e59676.
39. Chong MS, Goh LK, Lim WS, Chan M, Tay L, Chen G, Feng L, Ng TP, Tan CH, Lee TS. Gene expression profiling of peripheral blood leukocytes shows consistent longitudinal downregulation of TOMM40 and upregulation of KIR2DL5A, PLOD1, and SLC2A8 among fast progressors in early Alzheimer’s disease. J Alzheimers Dis 2013;34:399-405.
40. Chen X, Huang T, Zhang J, Song J, Chen L, Zhu Y. Involvement of calpain and p25 of CDK5 pathway in ginsenoside Rb1’s attenuation of beta-amyloid peptide25-35-induced tau hyperphosphorylation in cortical neurons. Brain Res 2008;1200:99-106